SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 14, 2003 HALSEY DRUG CO., INC. 695 North Perryville Road, Rockford, Illinois 61107 (815-399-2060) Incorporated under the Commission File Number I.R.S. Employer laws of State of New York 1-10113 Identification Number 11-0853640 Item 12. Results of Operations and Financial Condition On August 14, 2003, Halsey Drug Co., Inc. (the "Company") issued a press release disclosing the financial results for its second quarter ended June 30, 2003 and the six months ended June 30, 2003. A copy of the Company's press release is attached as Exhibit 99.1 hereto. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (b) Exhibits Exhibit Number Description ------ ----------- 99.1 Press Release dated August 14, 2003 Announcing Results for Second Quarter ended June 30, 2003 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. HALSEY DRUG CO., INC. By: /s/ Peter A. Clemens --------------------------- Peter A. Clemens Vice President & Chief Financial Officer Date: August 15, 2003 3 EXHIBIT INDEX ------------- Exhibit Number Description ------ ----------- 99.1 Press Release dated August 14, 2003 Announcing Results for Second Quarter ended June 30, 2003. 4